On Monday, Skye Bioscience Inc (NASDAQ: SKYE) was -13.01% drop from the session before settling in for the closing price of $1.73. A 52-week range for SKYE has been $1.14 – $5.96.
Healthcare Sector giant saw their annual sales surged by 42.99% over the last five years. When this article was written, the company’s average yearly earnings per share was at -92.81%. With a float of $18.10 million, this company’s outstanding shares have now reached $30.99 million.
The firm has a total of 16 workers. Let’s measure their productivity.
Skye Bioscience Inc (SKYE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Skye Bioscience Inc stocks. The insider ownership of Skye Bioscience Inc is 41.59%, while institutional ownership is 27.40%. The most recent insider transaction that took place on Aug 22 ’25, was worth 582,936. In this transaction Director of this company sold 170,449 shares at a rate of $3.42, taking the stock ownership to the 57,493 shares. Before that another transaction happened on Aug 21 ’25, when Company’s Director sold 60,956 for $3.57, making the entire transaction worth $217,613. This insider now owns 63,963 shares in total.
Skye Bioscience Inc (SKYE) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.1 earnings per share (EPS) during the time that was better than consensus figure (set at -0.25) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -92.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -22.03% during the next five years compared to 42.99% growth over the previous five years of trading.
Skye Bioscience Inc (NASDAQ: SKYE) Trading Performance Indicators
You can see what Skye Bioscience Inc (SKYE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.07, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.22 in one year’s time.
